HIV treatment and prevention 2019: current standards of care

N Phanuphak, RM Gulick - Current Opinion in HIV and AIDS, 2020 - journals.lww.com
HIV treatment and prevention 2019: current standards of care : Current Opinion in HIV and
AIDS HIV treatment and prevention 2019: current standards of care : Current Opinion in HIV …

The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis

E Krupka, S Curtis, T Ferguson, R Whitlock… - Clinical Journal of the …, 2022 - journals.lww.com
Results Of the 4758 eligible studies, 26 met the inclusion criteria, including nine studies that
recruited 488 transgender men and 593 women in which data were meta-analyzed. There …

Multilevel barriers to HIV PrEP uptake and adherence among Black and Hispanic/Latinx transgender women in Southern California

A Ogunbajo, ED Storholm, AJ Ober, LM Bogart… - AIDS and Behavior, 2021 - Springer
Abstract Black and Hispanic/Latinx transgender women in the United States (US) are
disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) reduces risk of HIV …

[图书][B] Directrices sobre la atención para el aborto

World Health Organization - 2022 - books.google.com
Capítulo 1. Introducción el de la La salud sexual y reproductiva es fundamental para las
personas, las parejas y las familias, pero también para desarrollo social y económico de las …

Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the …

KA Konda, TS Torres, G Mariño… - Journal of the …, 2022 - Wiley Online Library
Introduction The HIV epidemic continues to disproportionately impact Latin‐American
transgender women (TGW). We assessed factors associated with long‐term pre‐exposure …

Transgender women on oral HIV pre‐exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when …

E Shieh, MA Marzinke, EJ Fuchs… - Journal of the …, 2019 - Wiley Online Library
Abstract Introduction Oral HIV Pre‐Exposure Prophylaxis (PrEP) with tenofovir (TFV)
disoproxil fumarate (TDF)/emtricitabine (FTC) is highly effective. Transgender women (TGW) …

Sex hormone therapy and tenofovir diphosphate concentration in dried blood spots: primary results of the interactions between antiretrovirals and transgender …

RM Grant, M Pellegrini, PA Defechereux… - Clinical Infectious …, 2021 - academic.oup.com
Background Sex hormone and preexposure prophylaxis (PrEP) drug interactions among
transgender women (TGW), transgender men (TGM), and cisgender men (CGM) are not fully …

PrEP discontinuation among Latino/a and Black MSM and transgender women: A need for PrEP support services

O Nieto, RA Brooks, A Landrian, A Cabral… - PLoS …, 2020 - journals.plos.org
Purpose Disparities persist in HIV infection among Black and Latino men who have sex with
men (BLMSM) and Black and Latina transgender women (BLTW). Increasing uptake and …

HIV testing and PrEP use in a national probability sample of sexually active transgender people in the United States

JM Sevelius, T Poteat, WE Luhur… - JAIDS Journal of …, 2020 - journals.lww.com
Background: HIV testing and pre-exposure prophylaxis (PrEP) are effective HIV prevention
strategies often underused by transgender people. Methods: Recruitment occurred in 2 …

A comparison of attitudes and knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for …

A Rayanakorn, S Chautrakarn, K Intawong… - PLoS …, 2022 - journals.plos.org
Background HIV Pre-exposure prophylaxis (PrEP) has demonstrated efficacy and
effectiveness among high-risk populations. In Thailand, PrEP has been included in the …